Trial Profile
Evaluation of the efficacy of rosuvastatin in daily practice in untreated high risk patients (CHALLENGE)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jan 2008
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms CHALLENGE
- Sponsors AstraZeneca
- 08 Jan 2008 New trial record.